Pharmaceutical Executive Daily: The Launch of TrumpRx

Feb 06, 06:29 PM

Headliner
Share
Subscribe

In today’s Pharmaceutical Executive Daily, TrumpRx officially launches, the FDA moves against mass marketing of illegal copycat drugs, and AI emerges as a force multiplier for small and mid-size biotech companies

Share
Subscribe
Next
Pharmaceutical Executive Daily: Hims & Hers Removes Access to New Compounded Semaglutide Pill
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive